region specificity in endogenous opioid peptides and mu-opioid receptor gene expression in rat brain areas involved in addiction after frequent morphine treatment

Backgrounds: molecular mechanisms involved in adverse effects of morphine, including tolerance and dependence, have remained elusive. we examined possible alterations in the gene expression of proenkephalin (penk), prodynorphin (pdyn), and muopioid receptor (oprm1) in reward brain areas following frequent morphine treatment. methods: two groups of male wistar rats were used. the groups received either saline (1 ml/kg) or morphine (10 mg/kg) twice daily for eight days. on day 8, rats were decapitated, brain areas involved in addiction were dissected, including the midbrain, striatum, prefrontal cortex (pfc), hippocampus, and hypothalamus, and gene expression was evaluated with real-time pcr. results: prolonged morphine treatment decreased penk, pdyn, and oprm1 gene expressions in the midbrain but upregulated them in the striatum compared to the control group treated with saline. significant increases in pdyn and oprm1 gene expressions were detected in the pfc, but there was no significant difference in penk gene expression between the two groups. besides, pdyn gene expression was decreased in the hippocampus and hypothalamus; however, no significant differences in penk and oprm1 gene expressions were detected between the groups in these areas. conclusions: the expression of endogenous opioid peptides and receptors after frequent use of morphine follows a region specificity in brain areas involved in addiction. these alterations may result in new physiological setpoints outside the normal range, which need to be considered when using morphine in medicine.